- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Fayetteville, Arkansas, United States
- GSK Investigational Site Jonesboro, Arkansas, United States
- GSK Investigational Site Fresno, California, United States
Clinical trial condition
Haemophilus Influenzae Type b
Explore clinical trials studying Haemophilus Influenzae Type b. Study availability and eligibility vary by location and protocol.
83 public trials
1 recruiting study
Haemophilus Influenzae Type b trial results
NCT00129116
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Asse, Belgium
- GSK Investigational Site Drongen, Belgium
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site Maldegem, Belgium
NCT00127855
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site North Adelaide, South Australia, Australia
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Subiaco, Western Australia, Australia
NCT00586612
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Barcelona, Spain
- GSK Investigational Site Bilbao, Spain
- GSK Investigational Site Burgos, Spain
- GSK Investigational Site Getafe, Spain
NCT00197782
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
- Locations
-
Not specified
NCT00326118
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
- Locations
-
- GSK Investigational Site Garran, Australian Capital Territory, Australia
- GSK Investigational Site Randwick, New South Wales, Australia
- GSK Investigational Site Westmead, New South Wales, Australia
- GSK Investigational Site Herston, Queensland, Australia
NCT00129129
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Little Rock, Arkansas, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Centennial, Colorado, United States
- GSK Investigational Site Norwich, Connecticut, United States
Completed
Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine
NCT00289783
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Birmingham, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Bryant, Arkansas, United States
NCT01248884
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Santo Domingo, Dominican Republic
- GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
- GSK Investigational Site Espoo, Finland
- GSK Investigational Site Helsinki, Finland
NCT01090453
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Vancouver, British Columbia, Canada
- GSK Investigational Site Winnipeg, Manitoba, Canada
- GSK Investigational Site Hamilton, Ontario, Canada
- GSK Investigational Site Aix-en-Provence, France